Coverage rate of opportunistic and organised breast cancer screening in France: Department-level estimation.

Breast cancer screening programme Coverage Mammography Opportunistic screening Organised screening

Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 24 03 2022
revised: 19 09 2022
accepted: 27 09 2022
pubmed: 11 10 2022
medline: 11 10 2022
entrez: 10 10 2022
Statut: ppublish

Résumé

In France, the national breast cancer screening programme (NBCSP), targeting women aged 50-74 years was rolled out nationwide in 2004. It aims at reducing breast cancer mortality. In addition to the NBCSP, the use of opportunistic screening is permitted in France. The objective of this study is to estimate both opportunistic use and overall coverage rates of breast cancer screening, among women 40-84 years of age, in France. The French medico-administrative health data system (SNDS) was used to identify women performing an opportunistic or organised mammography screening in France in 2016-2017. The two-yearly opportunistic mammography screening is 18 % among women aged 40-84; it is 11 % among women aged 50-74, i.e., the target age range for organised screening, 36 % among women aged 40-49 and 13 % among women aged 75-84. The overall two-yearly screening coverage is 48 % for all women aged 40-84; it is 60 % among women aged 50-74, 36 % among women 40-49 and 16 % for those aged 75-84. Geographical variations in screening are lessened when the two screening strategies are considered, as they balance each other. Although coverage in the NBCSP is around 50 % in France, more than one third of the women make use of opportunistic screening within and outside the target age range. Organized screening appears to improve equity of access to mammography screening service. The lack of data on opportunistic screening practices hinders the evaluation of French screening practices as a whole.

Identifiants

pubmed: 36215917
pii: S1877-7821(22)00175-8
doi: 10.1016/j.canep.2022.102270
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102270

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Cécile Quintin (C)

National public health agency (Santé publique France), 12 rue du Val d'Osne, 94410 Saint Maurice, France. Electronic address: cecile.quintin@santepubliquefrance.fr.

Edouard Chatignoux (E)

National public health agency (Santé publique France), 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Julie Plaine (J)

National public health agency (Santé publique France), 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Françoise F Hamers (FF)

National public health agency (Santé publique France), 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Agnès Rogel (A)

National public health agency (Santé publique France), 12 rue du Val d'Osne, 94410 Saint Maurice, France.

Classifications MeSH